Two human leukocyte antigen (HLA) class I alleles are independently associated with an increased risk for allopurinol-induced ...
T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of all adult cancers, remain a ...
To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...
Patients with implanted medical devices like orthopedic joint replacements, pacemakers, and artificial heart valves run a ...
Data to be presented at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting on November 7th and 9thBOSTON and ...
Akari Therapeutics (AKTX) announced its abstract highlighting immune mechanism-of-action data for its novel ADC payload, PH1. The abstract is now ...
Enara’s discovery of DARKFOX delivers on the vision of translating the dark genome into a new class of clinically actionable ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the company has entered into an agreement to receive funds managed by Blackstone Life Sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback